Core Viewpoint - The Shenzhen Stock Exchange has publicly reprimanded Jinglan Technology Co., Ltd. and related parties for violations related to financial reporting and performance commitments [2][4]. Group 1: Violations and Disciplinary Actions - Jinglan Technology entered into an agreement in September 2018 to acquire 56.7152% of the shares of its subsidiary Zhongke Dingshi Environmental Engineering Co., Ltd. through a share issuance, with performance commitments to achieve a cumulative net profit of no less than 40 million yuan from 2018 to 2020 [2]. - In 2020, Zhongke Dingshi falsely recognized project completion and inflated revenue, costs, and profits to meet performance commitments, leading to significant misstatements in Jinglan Technology's annual report [3]. - The inflated figures included an increase in operating revenue by 162.91 million yuan (14.06% of reported revenue), operating costs by 96.55 million yuan (4.3% of reported costs), total profit by 66.36 million yuan (2.67% of total profit), and net profit by 57.71 million yuan (2.27% of net profit) [3]. Group 2: Disciplinary Measures - The Shenzhen Stock Exchange has decided to publicly reprimand Jinglan Technology and its former executives, including the chairman, president, vice president, and financial officer, for their roles in the violations [5]. - The disciplinary actions are based on the company's failure to adhere to the Stock Listing Rules and the lack of diligence and integrity from the executives involved [4][5]. - The company and the individuals have the right to apply for a review of the disciplinary decision within fifteen trading days [5].

Core Viewpoint - China Evergrande Group has been delisted from the Hong Kong Stock Exchange due to failure to meet the resumption requirements, marking the end of its 16-year presence in the capital market [1] Financial Misconduct - China Evergrande inflated its revenue by over 560 billion yuan in 2019 and 2020, with a total of 564.15 billion yuan in inflated revenue and 92.01 billion yuan in inflated profits [2] - The former Vice Chairman and President, Xia Haijun, was fined 15 million yuan and banned for life from the securities market due to his role in the financial misconduct [2] Debt Situation - As of June 30, 2023, China Evergrande's total liabilities amounted to 2.39 trillion yuan, total assets were 1.74 trillion yuan, and net assets were -644.2 billion yuan, indicating a severe financial crisis [2] Legal and Operational Developments - The chairman, Xu Jiayin, has been taken into custody for suspected illegal activities, and former executives have also faced legal actions [3] - China Evergrande has filed for liquidation in Hong Kong, with the court ruling that only statutory creditors can participate in the liquidation process, excluding economic interest holders [4] Asset Management - The liquidators revealed that Evergrande has less than 10 billion HKD in overseas assets available for disposal, including shares in Evergrande Property and stakes in Evergrande Auto [4] - Legal actions have been initiated to recover 6 billion USD in dividends and salaries from former executives, including Xu Jiayin and his ex-wife [4] Market Valuation - Once valued at 400 billion HKD in 2017, China Evergrande's market capitalization has plummeted to approximately 2.15 billion HKD, reflecting a significant decline in investor confidence [6]

Core Viewpoint - NuoTai Bio has been penalized for financial misconduct, including inflating revenue and profits, leading to significant fines and a change in stock status to ST NuoTai [1][2] Group 1: Financial Misconduct - NuoTai Bio inflated its 2021 revenue by 30 million yuan and profit by 25.9516 million yuan, which accounted for 20.64% of the reported total profit for that year [1] - Despite the inflated figures, the company's actual performance showed a revenue increase of 13.58% to 644 million yuan, while net profit decreased by 6.52% to 115 million yuan [1] Group 2: Regulatory Actions and Penalties - The China Securities Regulatory Commission (CSRC) issued a total fine of 4.74 million yuan to NuoTai Bio for two main violations: information disclosure and fabrication of significant false content in public offering documents [2] - The actual controller of NuoTai Bio, Zhao Dezhong, was fined 18 million yuan, while other executives involved faced fines ranging from 1.5 million to 3.3 million yuan [2] Group 3: Stock Market Impact - Following the penalties, NuoTai Bio's stock was subjected to risk warnings and was suspended from trading, with its stock name changed to ST NuoTai starting July 22 [2]